James A Saltsman1, Marcus M Malek1, Victor E Reuter2, William J Hammond1, Enrico Danzer1, Harry W Herr3, Michael P LaQuaglia4. 1. Pediatric Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. 2. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY. 3. Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. 4. Pediatric Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: laquaglm@mskcc.org.
Abstract
PURPOSE: Bladder cancer is the sixth most common cancer in the United States, but is exceedingly rare in young patients, leading to a lack of accepted standards for diagnosis, treatment, and surveillance. We review our institutional experience with bladder urothelial neoplasms in pediatric and young adult patients summarizing presentation, treatment, and outcomes. METHODS: Surgical pathology records at our institution were searched for cases of urothelial neoplasms among patients ≤25 years of age treated between January 1997 and September 2016. Cases submitted exclusively for pathology review were excluded. Diagnoses were confirmed based on pathologic examination using the 2004 World Health Organization classification system. RESULTS: Thirty-four patients were identified with a mean age of 21.1 years (range 8-25 years), and median follow-up was 25.1 months (1-187 months). The male to female ratio was 1.83:1. The most common presenting symptom was hematuria (n=26; 76%). Diagnoses were invasive urothelial carcinoma (n=3), noninvasive urothelial carcinoma (n=24), PUNLMP (n=6), and urothelial papilloma (n=1). Noninvasive lesions were resected by cystoscopy, after which 12% (n=4) experienced complications (grade II or greater). One patient with stage IV invasive disease at diagnosis died, and 2 patients developed recurrences. Of those with noninvasive carcinoma, 29% (n=7) required repeat cystoscopy soon after initial TURBT at outside institutions, and 17% (n=4) had tumors downgraded from high-grade to low-grade after pathology review. CONCLUSION: Hematuria is the most common sign of bladder neoplasia in children and young adults and should be investigated by cystoscopy. The majority of urothelial neoplasms in these patients are noninvasive and can be successfully treated with transurethral resection. LEVEL OF EVIDENCE: Level IV (Retrospective study with no comparison group).
PURPOSE:Bladder cancer is the sixth most common cancer in the United States, but is exceedingly rare in young patients, leading to a lack of accepted standards for diagnosis, treatment, and surveillance. We review our institutional experience with bladder urothelial neoplasms in pediatric and young adult patients summarizing presentation, treatment, and outcomes. METHODS: Surgical pathology records at our institution were searched for cases of urothelial neoplasms among patients ≤25 years of age treated between January 1997 and September 2016. Cases submitted exclusively for pathology review were excluded. Diagnoses were confirmed based on pathologic examination using the 2004 World Health Organization classification system. RESULTS: Thirty-four patients were identified with a mean age of 21.1 years (range 8-25 years), and median follow-up was 25.1 months (1-187 months). The male to female ratio was 1.83:1. The most common presenting symptom was hematuria (n=26; 76%). Diagnoses were invasive urothelial carcinoma (n=3), noninvasive urothelial carcinoma (n=24), PUNLMP (n=6), and urothelial papilloma (n=1). Noninvasive lesions were resected by cystoscopy, after which 12% (n=4) experienced complications (grade II or greater). One patient with stage IV invasive disease at diagnosis died, and 2 patients developed recurrences. Of those with noninvasive carcinoma, 29% (n=7) required repeat cystoscopy soon after initial TURBT at outside institutions, and 17% (n=4) had tumors downgraded from high-grade to low-grade after pathology review. CONCLUSION:Hematuria is the most common sign of bladder neoplasia in children and young adults and should be investigated by cystoscopy. The majority of urothelial neoplasms in these patients are noninvasive and can be successfully treated with transurethral resection. LEVEL OF EVIDENCE: Level IV (Retrospective study with no comparison group).
Authors: Daniela Di Carlo; Andrea Ferrari; Katia Perruccio; Paolo D'Angelo; Anna Maria Fagnani; Giovanni Cecchetto; Gianni Bisogno Journal: Pediatr Blood Cancer Date: 2014-12-24 Impact factor: 3.167
Authors: P J Wild; J Giedl; R Stoehr; K Junker; S Boehm; J M M van Oers; E C Zwarthoff; H Blaszyk; S W Fine; P A Humphrey; L P Dehner; M B Amin; J I Epstein; A Hartmann Journal: J Pathol Date: 2007-01 Impact factor: 7.996
Authors: Javier Lerena; Lucas Krauel; Luis García-Aparicio; Santiago Vallasciani; Mariona Suñol; Joan Rodó Journal: J Pediatr Urol Date: 2010-01-18 Impact factor: 1.830
Authors: Maximilian Burger; Willem Oosterlinck; Badrinath Konety; Sam Chang; Sigurdur Gudjonsson; Raj Pruthi; Mark Soloway; Eduardo Solsona; Paul Sved; Marko Babjuk; Maurizio A Brausi; Christopher Cheng; Eva Comperat; Colin Dinney; Wolfgang Otto; Jay Shah; Joachim Thürof; J Alfred Witjes Journal: Eur Urol Date: 2012-09-05 Impact factor: 20.096
Authors: Bas W G van Rhijn; Theo H van der Kwast; André N Vis; Wim J Kirkels; Egbert R Boevé; Adriaan C Jöbsis; Ellen C Zwarthoff Journal: Cancer Res Date: 2004-03-15 Impact factor: 12.701
Authors: A Berrettini; M Castagnetti; A Salerno; S G Nappo; G Manzoni; W Rigamonti; P Caione Journal: J Pediatr Urol Date: 2014-09-28 Impact factor: 1.830
Authors: Jose M Martinez-Thomas; Luis F Galicia-Belaunzaran; Claudio E Merayo-Chalico; Joseph Palatchi; Juan Carlos Angulo-Lozano Journal: Cureus Date: 2022-05-14
Authors: Kata Davidovics; Sandor Davidovics; Andras Farkas; Noemi Benedek; Tamas Tornoczki; Daniel Kardos; Anna Davidovics; Peter Vajda Journal: European J Pediatr Surg Rep Date: 2020-04-23